Search

Your search keyword '"Parisi, Vincenzo"' showing total 395 results

Search Constraints

Start Over You searched for: Author "Parisi, Vincenzo" Remove constraint Author: "Parisi, Vincenzo"
395 results on '"Parisi, Vincenzo"'

Search Results

351. A preliminary study of the neuroprotective role of citicoline eye drops in glaucomatous optic neuropathy.

352. Sensorimotor trigeminal unbalance modulates pupil size.

353. Retinal nerve fiber layer thickness changes in Parkinson disease: a meta-analysis.

354. Single-session photodynamic therapy combined with intravitreal ranibizumab for neovascular age-related macular degeneration: a comprehensive functional retinal assessment.

355. Retinal function and neural conduction along the visual pathways in affected and unaffected carriers with Leber's hereditary optic neuropathy.

356. Reduced habituation of the retinal ganglion cell response to sustained pattern stimulation in multiple sclerosis patients.

357. Comparison of optic nerve head parameter measurements obtained by time-domain and spectral-domain optical coherence tomography.

358. Lateral inhibition in visual cortex of migraine patients between attacks.

359. Retinal nerve fiber layer thickness variability in Leber hereditary optic neuropathy carriers.

360. Macular function in eyes with open-angle glaucoma evaluated by multifocal electroretinogram.

361. Macular vitreoretinal interface abnormalities in highly myopic eyes with posterior staphyloma: 5-year follow-up.

362. Carotenoids in Age-related Maculopathy Italian Study (CARMIS): two-year results of a randomized study.

363. The influence of axial length on retinal nerve fibre layer thickness and optic-disc size measurements by spectral-domain OCT.

364. Retinal nerve fiber layer thickness in dominant optic atrophy measurements by optical coherence tomography and correlation with age.

365. Topical nerve growth factor as a visual rescue strategy in pediatric optic gliomas: a pilot study including electrophysiology.

366. Repeatability of optic nerve head parameters measured by spectral-domain OCT in healthy eyes.

367. Retinal functional changes measured by frequency-doubling technology in patients treated with hydroxychloroquine.

368. Ocular application of nerve growth factor protects degenerating retinal ganglion cells in a rat model of glaucoma.

369. Abnormal cortical responses to somatosensory stimulation in medication-overuse headache.

370. Changes in visual-evoked potential habituation induced by hyperventilation in migraine.

371. Electrophysiological detection of delayed postretinal neural conduction in human amblyopia.

372. OPA1 mutations associated with dominant optic atrophy influence optic nerve head size.

373. Lack of cold pressor test-induced effect on visual-evoked potentials in migraine.

374. Tonic pain abolishes cortical habituation of visual evoked potentials in healthy subjects.

375. Impact of regional retinal responses on cortical visually evoked responses: multifocal ERGs and VEPs in the retinitis pigmentosa model.

376. Lack of habituation in the light adapted flicker electroretinogram of normal subjects: a comparison with pattern electroretinogram.

377. Experimental and clinical evidence of neuroprotection by nerve growth factor eye drops: Implications for glaucoma.

378. Glaucoma alters the expression of NGF and NGF receptors in visual cortex and geniculate nucleus of rats: effect of eye NGF application.

379. Fellow eye findings of highly myopic subjects operated for retinal detachment associated with a macular hole.

380. Carotenoids and antioxidants in age-related maculopathy italian study: multifocal electroretinogram modifications after 1 year.

381. Intraocular pressure and central corneal thickness.

382. Evidence of the neuroprotective role of citicoline in glaucoma patients.

383. Macular function in eyes with early age-related macular degeneration with or without contralateral late age-related macular degeneration.

384. Acute retinal ganglion cell injury caused by intraocular pressure spikes is mediated by endogenous extracellular ATP.

385. Posterior vitreous detachment and retinal detachment after cataract surgery.

386. Assessment of macular function by focal electroretinogram and pattern electroretinogram before and after epimacular membrane surgery.

387. Clinical ability of pattern electroretinograms and visual evoked potentials in detecting visual dysfunction in ocular hypertension and glaucoma.

388. Prevalence of asymptomatic macular holes in highly myopic eyes.

389. Macular function after PDT in myopic maculopathy: psychophysical and electrophysiological evaluation.

390. Electrophysiological assessment of glaucomatous visual dysfunction during treatment with cytidine-5'-diphosphocholine (citicoline): a study of 8 years of follow-up.

391. Retinal detachment associated with macular hole in high myopia: using the vitreous anatomy to optimize the surgical approach.

392. Cataract surgery as a risk factor for retinal detachment in very highly myopic eyes.

393. Correlation between morphological and functional retinal impairment in patients affected by ocular hypertension, glaucoma, demyelinating optic neuritis and Alzheimer's disease.

394. Altered recovery of macular function after bleaching in Stargardt's disease-fundus flavimaculatus: pattern VEP evidence.

395. Development of macular pseudoholes: a 36-month period of follow-up.

Catalog

Books, media, physical & digital resources